Skip to main content
. 2018 Oct 27;2018:bcr2018225528. doi: 10.1136/bcr-2018-225528

Figure 1.

Figure 1

Alterations of clinical presentation of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms and autoimmune sequelae. (A) At the initial presentation, the patient had purplish and erythematous plaques on the face. (B) The partial hair loss started 7 months after onset of the disease. (C) Total hair loss associated with generalised vitiligo after 21 months.